Kalidase Tablet (Kalidino-genase)

Adult dose

Administer 30~150I.U. per day orally in 3 divided doses (take, administer). The dose may be adjusted appropriately according to age and symptoms.

This medication should not be used in patients with bleeding, such as those who have just experienced a cerebral hemorrhage. Additionally, as this medication contains lactose, patients who are genetically unable to break down lactose, for example, those with galactose intolerance or lactase deficiency, and those with glucose-galactose malabsorption should not take this medication. This medication contains a dye called Yellow No. 5, so patients who have had allergies or hypersensitivity to this ingredient should be especially cautious when using this medication. While taking this medication, allergic reactions such as rash or itching may rarely occur, so if these symptoms develop, the medication should be stopped immediately. Furthermore, occasionally symptoms such as palpitations, gastrointestinal discomfort, nausea, vomiting, reduced appetite, abdominal pain, diarrhea, or constipation may occur. In addition, a feeling of warmth in the body, headache, drowsiness, and fatigue have been reported rarely, so it is advisable to consult a doctor if these symptoms occur. Especially in older adults, as body functions may be weakened, careful usage such as reducing the dosage should be considered when taking this medication.

• rash
• itching
• palpitations
• discomfort in the stomach
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is best to maintain storage temperature between 1 and 30 degrees Celsius at room temperature. This will help preserve the effectiveness of the medication and ensure safe use.

Appearance

Orange round enteric-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle